Thrombophilia and placental pathology

Clinical Obstetrics and Gynecology

Volumn 49, Issue 4, 2006, Pages 885-894

  Redline, Raymond W ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Fetal thrombotic vasculopathy; Infarction; Maternal underperfusion; Pathology; Placenta; Thrombophilia

Indexed keywords

PHOSPHOLIPID ANTIBODY;

BLOOD CLOTTING DISORDER; FETUS CIRCULATION; FETUS WASTAGE; HUMAN; NONHUMAN; PATHOLOGY; PLACENTA; PREECLAMPSIA; PREGNANCY DISORDER; PREGNANCY OUTCOME; REVIEW; THROMBOPHILIA;

ABORTION, HABITUAL; FEMALE; HUMANS; PLACENTA; PLACENTA DISEASES; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY OUTCOME; THROMBOPHILIA;

EID: 33750628001     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.grf.0000211957.68745.6b     Document Type: Review

References (22)

1. Robertson L, Wu O, Langhorne P, et al. Thrombophilia in pregnancy: a systematic review. Br J Haematol. 2006;132:171-196.
2. Kraus FT, Redline R, Gersell DJ, et al. Placental Pathology. Washington, DC: American Registry of Pathology; 2004.
3. Redline RW, Boyd T, Campbell V, et al. Maternal vascular underperfusion: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol. 2004;7:237-249.
4. Jauniaux E, Hempstock J, Greenwold N, et al. Trophoblastic oxidative stress in relation to temporal and regional differences in maternal placental blood flow in normal and abnormal early pregnancies. Am J Pathol. 2003;162:115-125.
5. Isermann B, Sood R, Pawlinski R, et al. The thrombomodulin-protein C system is essential for the maintenance of pregnancy. Nat Med. 2003;9:331-337. Epub 2003 Feb 2010.
6. Franchi F, Biguzzi E, Cetin I, et al. Mutations in the thrombomodulin and endothelial protein C receptor genes in women with late fetal loss. Br J Haematol. 2001;114:641-646.
7. Bose P, Black S, Kadyrov M, et al. Adverse effects of lupus anticoagulant positive blood sera on placental viability can be prevented by heparin in vitro. Am J Obstet Gynecol. 2004;191:2125-2131.
8. Thurman JM, Holers VM. The central role of the alternative complement pathway in human disease. J Immunol. 2006;176:1305-1310.
9. Rand JH, Arslan AA, Wu XX, et al. Reduction of circulating annexin A5 levels and resistance to annexin A5 anticoagulant activity in women with recurrent spontaneous pregnancy losses. Am J Obstet Gynecol. 2006;194:182-188.
10. Mousa HA, Alfirevic Z. Do placental lesions reflect thrombophilia state in women with adverse pregnancy outcome? Hum Reprod. 2000;15:1830-1833.
11. Dizon-Townson DS, Meline L, Nelson LM, et al. Fetal carriers of the factor V Leiden mutation are prone to miscarriage and placental infarction. Am J Obstet Gynecol. 1997;177:402-405.
12. Sebire NJ, Backos M, El Gaddal S, et al. Placental pathology, antiphospholipid antibodies, and pregnancy outcome in recurrent miscarriage patients. Obstet Gynecol. 2003;101:258-263.
13. Heller DS, Rush D, Baergen RN. Subchorionic hematoma associated with thrombophilia: report of three cases. Pediatr Dev Pathol. 2003;6:261-264.
14. Van Horn JT, Craven C, Ward K, et al. Histologic features of placentas and abortion specimens from women with antiphospholipid and antiphospholipid- like syndromes. Placenta. 2004;25:642-648.
15. Baergen RN, Rush D, Chacko S, et al. Placental pathology in thrombophilias (TH) before and after anticoagulant therapy. Pediatr Dev Pathol. 2004;7:96A.
16. Redline RW. Severe fetal placental vascular lesions in term infants with neurologic impairment. Am J Obstet Gynecol. 2005;192:452-457.
17. Redline RW, Ariel I, Baergen RN, et al. Fetal vascular obstructive lesions: nosology and reproducibility of placental reaction patterns. Pediat and Devel Pathol. 2004;7:443-452.
18. Vern TZ, Alles AJ, KowalVern A, et al. Frequency of factor V-Leiden and prothrombin G20210A in placentas and their relationship with placental lesions. Hum Pathol. 2000;31:1036-1043.
19. Ariel I, Anteby E, Hamani Y, et al. Placental pathology in fetal thrombophilia. Hum Pathol. 2004;35:729-733.
20. Leistra-Leistra MJ, Timmer A, vanSpronsen FJ, et al. Fetal thrombotic vasculopathy in the placenta: a thrombophilic connection between pregnancy complications and neonatal thrombosis? Placenta. 2004;25(suppl A):S102-S105.
21. Khong TY, Hague WM. Biparental contribution to fetal thrombophilia in discordant twin intrauterine growth restriction. Am J Obstet Gynecol. 2001;185:244-245.
22. Redline RW. Clinical and pathological umbilical cord abnormalities in fetal thrombotic vasculopathy. Hum Pathol. 2004;35:1494-1498.